Basit öğe kaydını göster

dc.contributor.authorAKOVA, YA
dc.contributor.authorTUGALTUTKUN, I
dc.contributor.authorFOSTER, CS
dc.date.accessioned2021-03-05T20:44:25Z
dc.date.available2021-03-05T20:44:25Z
dc.date.issued1995
dc.identifier.citationTUGALTUTKUN I., AKOVA Y., FOSTER C., "Penetrating keratoplasty in cicatrizing conjunctival diseases.", Ophthalmology, cilt.102, ss.576-85, 1995
dc.identifier.issn0161-6420
dc.identifier.otherav_d5a0bfa6-b631-4954-bdf9-7aadd158f953
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/140955
dc.identifier.urihttps://doi.org/10.1016/s0161-6420(95)30980-3
dc.description.abstractPurpose: The outcome of successful penetrating keratoplasty (PK) typically is poor in eyes with end-stage chronic cicatrizing conjunctival diseases such as ocular cicatricial pemphigoid (OCP), Stevens-Johnson syndrome, and toxic epidermal necrolysis due to immunologically driven conjunctival inflammation associated with conjunctival cicatrization and lid abnormalities, severe dry eye, and extensive corneal neovascularization. The authors report the results of their experience with PK in 13 patients with OCP, Stevens-Johnson syndrome, and toxic epidermal necrolysis.
dc.language.isoeng
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectOFTALMOLOJİ
dc.titlePenetrating keratoplasty in cicatrizing conjunctival diseases.
dc.typeMakale
dc.relation.journalOphthalmology
dc.contributor.department, ,
dc.identifier.volume102
dc.identifier.issue4
dc.identifier.startpage576
dc.identifier.endpage85
dc.contributor.firstauthorID116124


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster